Peak-to-trough ratio
Peak-to-trough ratio is a pharmacokinetic parameter that is used to describe the fluctuation of drug concentration in the body over a dosing interval. It is calculated as the ratio of the maximum (peak) concentration (Cmax) to the minimum (trough) concentration (Cmin) of a drug in the body. The peak-to-trough ratio is an important factor in determining the dosing regimen of a drug and can influence the efficacy and safety of the drug.
Calculation[edit | edit source]
The peak-to-trough ratio is calculated by dividing the maximum concentration of the drug (Cmax) by the minimum concentration of the drug (Cmin). This ratio provides a measure of the fluctuation of drug concentration in the body over a dosing interval.
Importance[edit | edit source]
The peak-to-trough ratio is an important factor in determining the dosing regimen of a drug. A high peak-to-trough ratio may indicate a large fluctuation in drug concentration, which could lead to periods of sub-therapeutic or toxic drug levels. Conversely, a low peak-to-trough ratio may indicate a more constant drug concentration, which could lead to more consistent therapeutic effects.
Factors affecting peak-to-trough ratio[edit | edit source]
Several factors can affect the peak-to-trough ratio, including the absorption, distribution, metabolism, and excretion (ADME) of the drug, the dosing regimen, and individual patient factors. For example, drugs that are rapidly absorbed and eliminated will have a higher peak-to-trough ratio than drugs that are slowly absorbed and eliminated.
Clinical implications[edit | edit source]
The peak-to-trough ratio can have important clinical implications. For example, drugs with a high peak-to-trough ratio may be associated with a higher risk of adverse effects, while drugs with a low peak-to-trough ratio may be associated with a lower risk of adverse effects. Therefore, understanding the peak-to-trough ratio can help clinicians optimize drug therapy and minimize the risk of adverse effects.
See also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD